As of Feb 26
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for StemCells Inc have a median target of 3.63, with a high estimate of 5.00 and a low estimate of 2.25. The median estimate represents a +232.57% increase from the last price of 1.09.
The current consensus among 2 polled investment analysts is to Buy stock in StemCells Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.